Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome

Dysbiosis of the intestinal microbiota has been implicated in insulin resistance, although evidence regarding causality in humans is scarce. We performed a phase I/II dose-finding and safety study on the effect of oral intake of the anaerobic butyrogenic strain Anaerobutyricum soehngenii on glucose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Biofilms Microbiomes
Autors principals: Gilijamse, Pim W., Hartstra, Annick V., Levin, Evgeni, Wortelboer, Koen, Serlie, Mireille J., Ackermans, Mariette T., Herrema, Hilde, Nederveen, Aart J., Imangaliyev, Sultan, Aalvink, Steven, Sommer, Morton, Levels, Han, Stroes, Erik S. G., Groen, Albert K., Kemper, Marleen, de Vos, Willem M., Nieuwdorp, Max, Prodan, Andrei
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7101376/
https://ncbi.nlm.nih.gov/pubmed/32221294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41522-020-0127-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars